ABSTRACT
Introduction
QT interval refers to the period between ventricular depolarization and repolarization observed on electrocardiogram.
It includes the period from the onset of the QRS complex to when the T wave returns to the isoelectric line. QT interval changes with heart rate (HR) and QT corrected for heart rate is named QTc.
It is known that many anesthetic agents, such as sevoflourane and opioids, prolong the QT interval on ECG. Prolongation of QT interval linked to medication may speed up life-threatening arrhythmias like torsades de point and cause a variety of cardiovascular complications [1] [2] [3] .
Muscle relaxants are routinely used as an important component of general anesthesia. Neostigmine is the agent most frequently used to remove non-depolarizing block during general anesthesia [4] [5] . However used alone neostigmine may cause a variety of side effects such as nausea, vomiting, prolonged QT interval and bronchoconstriction. The use of atropine aims to antagonize these effects 6 . Studies have proposed sugammadex, a cyclodextrine analogue, as a fast and reliable agent to remove non-depolarizing block 7 . In addition use of sugammadex has been determined to cause hypotension, cough and nausea. However studies are available showing that sugammadex has minimal effect on QT interval.
The hypothesis of our study is that sugammadex will have less effect on the QT c interval on ECG compared to the combination of atropine+neostigmine. In this study we created a general anesthesia model using rabbits to evaluate only the effects of general anesthesia without surgical stimulus. We aimed to compare the effects of sugammadex and neostigmine on the QT c interval when used to antagonize the effects of rocuronium.
Methods
This study used 10 adult white New Zealand rabbits weighing 2. Before the study began the rabbits were clinically evaluated for behavior, respiratory and cardiovascular system problems and no negative result was found for animals included in the study. All experiments took place between 09.00 and 16.00. During the experiments the animals were fed with standard rabbit food and were given continuous access to water.
The temperature of the shelter was kept at 21±2˚C. The animals were randomly divided into two groups: the sugammadex group (Group S, n:5) and neostigmine group (Group N, n:5). Rabbits included in the study were fasted for eight hours prior to the anesthesia induction. Before general anesthesia, all rabbits were administered 10 mg/kg ketamine for premedication. After waiting 20 minutes, the animals were monitored with ECG.
Then a vein was opened in the ear using a 26 G branula and Ltd. Yokohama, JAPAN). At 25 minutes after induction Group N rabbits were given 0.05 mg/kg iv neostigmine + 0.01 mg/kg iv atropine. Group S were administered 2 mg/kg iv sugammadex.
When the rabbits' spontaneous respiration was observed at sufficient levels, the V-Gel Rabbit was removed and animals were taken to recovery. 8 The electrodes at the extremities were used to take measurements at basal (0 min.) and at 2nd, 5th, 10th, 20th, 25th, 27th, and 30th minutes after intubation.
Comparison of effects of sugammadex and neostigmine on QT c prolongation in rabbits under
ECG data was converted to a digital environment (Poly-Spectrum 12 channel ECG-System, Poly-Spectrum-8, Neurosoft, 5, Voronin str., Ivanovo, Russia). ECG records were converted to 1 mV=20 mm, rate 50 mm/s and filter (35 Hz) and the I, II, III, aVR, aVL and aVF derivations were recorded. The QT interval was calculated as the period from the start of the Q wave to the end of the T wave. Corrected QT interval (QTc) was calculated according to the formula reported by Bazett 9 .
Statistical analysis
All statistical analysis was performed using SPSS 
Results
The average weight of rabbits in the sugammadex group was 2.9±0.5 kg while the neostigmine group had an average weight of 3±0.4 kg, with no statistically significant difference. The study results from Group S and Group N showed no statistically significant difference in terms of blood gas parameters (Table 1 ).
In addition the mean arterial pressure and heart rate values from both groups were similar during the experiment (Tables 2 and 3 ). Comparing the QT c interval in the rabbits in Group S and Group N, the measurements at 5th, 15th and 20th minutes were similar to basal readings. However at the 25th, 27th and 30th minutes after muscle relaxant antagonist was administered the QT c interval in the neostigmine group rabbits was significantly prolonged (Figure 1 ).
Group

Discussion
This study created a model to evaluate the effects of general anesthesia without surgical stress. We observed that the use of neostigmine+atropine significantly increased the QT c interval on ECG compared to sugammadex.
The administration of anesthesia affects the QT interval at varying stages. Autonomic nerve system changes developing especially during general anesthesia cause changes in the QT interval 10 . Fear before surgery, agents used for anesthetic induction, laryngoscopy and endotracheal intubation procedures or developing hemodynamic and neuroendocrine responses have been researched to explain rhythm disorders observed on electrocardiography 11, 12 .
Muscle relaxants are widely used to make endotracheal intubation easier during anesthesia induction and to provide the muscle relaxation which is necessary for surgery. While the effect of muscle relaxants on the patient may have clinically ended, some of the nerve-muscle junction receptors may be blocked by muscle relaxant agents. This situation is known as postoperative residual curarization (PORC). PORC is an important factor increasing the morbidity and mortality in the period after surgery 13 .
Neostigmine, a cholinesterase inhibitor, is an agent frequently used to remove non-depolarizing block during general anesthesia 14 . Used alone neostigmine may bring out side effects such as bradycardia and increased salivation. As a result to antagonize the side effects of neostigmine during removal of nondepolarizing block it is necessary to use muscarinic antagonists such as atropine 15 . However as the use of atropine stimulates the anti-muscarinic receptors, cardiovascular, gastrointestinal and respiratory side effects may be observed. The muscarinic antagonist agents may cause side effects such as tachycardia, blurred vision and sedation 16, 17 . A case study in the literature reported a patient operated under general anesthesia who developed heart block after neostigmine administration, followed by increased QT c interval, who responded to two doses of atropine and returned to normal 4 hours after the operation 18 . Medications used for reverse should both quickly remove the muscle relaxant effect and cause minimum side effects.
Sugammadex is a modified cyclodextrine agent which selectively binds to steroid-based muscle relaxants. As sugammadex directly binds to steroid-based muscle relaxants in plasma, it has no effects on the neuromuscular junction. As a result its effects start quickly and it causes fewer side effects 19 . Comparing sugammadex to neostigmine it is known to more quickly reverse the neuromuscular block produced by rocuronium under general anesthesia 20 . Cammu et al. 21 in a study of healthy volunteers used sugammadex after a single dose of rocuronium and vecuronium and observed important changes in vital signs on ECG. In another study it was determined that sugammadex with a dose of 1-8 mg/ kg minimally affected the QT c interval 3 . However sugammadex is only effective when used with steroid-based muscle relaxants 22 .
There is no experimental or clinical study evaluating the effects of atropine neostigmine combination and sugammadex on QT c interval in the literature. In our study we created a general anesthetic model in rabbits to evaluate the effects of sugammadex and neostigmine on QT c interval without surgical stimulus.
Compared with the atropine and neostigmine combination, we determined the QT c interval in rabbits treated with sugammadex was significantly shorter.
In our study after the airway device was inserted the QT c interval in both groups increased. During general anesthesia linked to medications used for both anesthetic induction and isoflurane used to maintain anesthesia, we observed an increase in QT c interval compared to basal values, though not at significant levels. After reverse while there was no change in the FIGURE 1 -Groups N and S the variation with time of the QT C interval. 25th, 27th and 30th minutes after muscle relaxant antagonist was administered the QT c interval in the neostigmine group rabbits was significantly prolonged.
QT c interval in the sugammadex group, the QT c interval in the neostigmine+atropine group significantly increased. We believe the increase in the neostigmine group may be linked to the antimuscarinic effects of atropine.
On the other hand we believe the lack of definite change in the sugammadex group may be related to sugammadex only binding with rocuronium in plasma and not affecting the nicotinic and muscarinic receptors.
Conclusion
While sugammadex administered to antagonize the effect of rocuronium did not significantly affect the QT c interval, however, neostigmine+atropine prolonged the QT c interval.
